World Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market forecast to 2020: report on key insights, industry drivers, market overview
Promising drug pipeline, evolving treatment patterns, emerging untapped non-metastatic CRPC space and augmented patient awareness are the factors that are expected to boost the market growth. Further, untapped CRPC market in the Asia-Pacific and LAMEA region would also accelerate the overall market growth during the forecast period. Untapped non-metastatic CRPC settings would further bolster the market growth. On the other hand, factors such as premium pricing of CRPC drugs, uncertain reimbursement policies and lack of differentiation in mechanism of action among the approved and novel agents are likely to curtail the market growth.
Check Complete Report @ http://www.marketintelreports.com/report/allied0164/world-castrationresistant-prostate-cancer-crpchrpca-therapeutics--market-opportunity-and-forecast-2014--2020
The market would gain traction in the developing regions of Asia-Pacific and third-world countries such as Africa and Latin America. The large undiagnosed patient population, rapid urbanization, rising disposable income, improved government funding towards cancer and growing awareness about prostate cancer would be some of the prime reasons responsible for the unparalleled market growth in these regions. However, oncologists/urologists reluctance towards adoption of these premium treatments in countries like India and China would continue to remain a key challenge for the leading innovators. To provide a detailed market assessment, the report segments the CRPC market on the basis of therapy type, drug delivery method and geography.
Based on therapy type, the market is segmented across various segments such as Chemotherapy, Hormonal Therapy, Immunotherapy and Radiotherapy. Hormonal therapy segment spearheads the therapy types market, governing around 4/5th of the global market value in 2014 and would continue to maintain its market position during the forecast period (2015-2020). Radiation therapy segment is projected as the fastest growing segment throughout the forecast period. Based on drug delivery method, the market is segmented into oral and injectable therapy segments. Oral therapy segment dominates the global CRPC market; however, injectable segment is expected to grow at a faster rate.
The report covers a geographic breakdown and a detailed analysis of each of the aforesaid segments across North America, Europe, Asia Pacific and LAMEA regions. North America region governs a dominant share in the global CRPC market; however, Asia-Pacific and LAMEA region are expected to register the highest CAGR during the forecast period. The market registered substantial growth in the recent years, owing to the various strategies adopted by leading market players.
Get Sample Brochure of the Report @
one of the key strategies adopted is collaboration agreement.
Astellas Pharma Inc. for instance in 2009, entered into an agreement with Medivation, Inc. to co-develop and co-commercialize MDV3100 (now Xtandi) for the treatment of CRPC. A comprehensive competitive analysis and profiles of major market players such as Astellas Inc., Johnson & Johnson, Sanofi S.A, Dendreon Corporation, Bayer AG, and others have been provided in the report.
KEY MARKET BENEFITS: This report provides an extensive analysis of the current and emerging market trends and dynamics in the global CRPC (metastatic and non-metastatic) market.
The CRPC market scenario is comprehensively analyzed in accordance to the key regions In-depth analysis of CRPC (chemotherapy and post-chemo) settings is implemented in the report
The market estimations are made in the report by conducting high-end analysis of the key market segments for the period of 2014-2020Extensive research is done for the market by therapy type which instils a clear understanding regarding the currently used therapy drugs and evolving role of immunotherapies and radiopharmaceuticals.
A detailed SWOT analysis enables to study the internal environment of the leading companies for strategy formulation Owing to an emerging pipeline in the market, pipeline analysis studies have also been taken into account to better understand the market potential and opportunities Competitive intelligence highlights the business practices followed by leading market players across geographies
KEY MARKET SEGMENTS: The Global CRPC market segmentation is illustrated below:
Global CRPC Market by Therapy Type Chemotherapy Cytotoxic Agents Hormonal TherapyAnti-AndrogensImmunotherapyVaccinesRadiotherapyRadio-Pharmaceuticals
Global CRPC Market by Drug Delivery Method Oral Therapy Injectable Therapy
Global CRPC Market by Geography: North America Europe Asia-Pacific LAMEA
MarketIntelReports (MIR) aim to empower our clients to successfully manage and outperform in their business decisions, we do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.
A group of industry veterans who are well experienced in reputed international consulting firms after identifying the sourcing needs of MNCs for market intelligence, have together started this business savior MarketIntelReports.
MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
MarketIntelReports currently has more than 10,000 plus titles and 35+ publishers on our platform and growing consistently to fill the “Global Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.
2711 Centerville Road, Suite 400,
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release World Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market forecast to 2020: report on key insights, industry drivers, market overview here
News-ID: 364755 • Views: 277
More Releases from MarketIntelReports
Study on Future Growth Drivers of the Cloud Integration Market
Cloud Integration or integration platform as a service (iPaaS) is one of the fast emerging forms of cloud computing services that are delivered to configure data with various application programs. These application programs range from enterprise risk management (ERM), customer relationship management (CRM), database management system (DBMS), and business process management to web conferencing, and emails, etc. Cloud integration services are especially designed to help organizations of all sizes to
Analysis of Variables Pushing the Expansion of the Workforce Management Market
Workforce Management is an integrated set of processes that an institution or organization uses to optimize the productivity of its employees on the individual, departmental, and entity-wide levels. This report identifies the Workforce Management market size in terms of value for the year 2014-2016, and forecast of the same for year 2021. It highlights potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges,
Study on Future Growth Drivers of the Blockchain Market
The blockchain technology market size is estimated to grow from USD 210.2 Million in 2016 to USD 2,312.5 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 61.5% during the forecast period. In the report, 2015 is considered the base year, while the forecast period is 2016–2021. The objective of the report is to define, describe, and forecast the blockchain technology market on the basis of providers, applications, deployment
Glass Bonding Adhesives Market by End-Use Industry (Furniture, Electronics, Medi …
The use of adhesives and glues as a bonding agent between glass and other materials is increasing now a days. The glass bonding adhesives has a wide range of applications in automotive industry for bonding the glass in vehicles, manufacturing of water tanks and optical glasses, bonding of window glass to frame or structure etc. The selection of a suitable adhesive for proper bonding of glass depends upon various factors
More Releases for CRPC
Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Siz …
Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining prominence in the prostate cancer market. The global CRPC market is poised to expand at a significant pace, owing to high unmet clinical need, limited survival benefits, growing prevalence rates and fast emerging treatment modifications. The market growth would pivot around the novel breakthrough
Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Industry: Global …
"The Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market report provides information by Top Players, Geography, End users, Applications, Competitor analysis, Sales, Revenue, Price, Gross Margin, Market Share, Import-Export, Trends and Forecast. Initially, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market analysis is provided for the international markets including development trends, competitive landscape analysis, and key
Castration-Resistant Prostate Cancer (CRPC) Treatment market report provides det …
Castration-Resistant Prostate Cancer (CRPC) Treatment market is expected to garner $+10 billion by 2025, registering a CAGR of +9 % during the forecast period 2016-2025. The growing preference for hormonal therapy is one of the major factor which drives the growth of the market. Also, Promising drug pipeline, evolving treatment patterns, emerging untapped non-metastatic CRPC space and augmented patient awareness are the factors that are expected to boost the market
Castration-Resistant Prostate Cancer (CRPC) Treatment Market- Evolving Manufactu …
HTF MI published a new industry research that focuses on Castration-Resistant Prostate Cancer (CRPC) Treatment market and delivers in-depth market analysis and future prospects of Global Castration-Resistant Prostate Cancer (CRPC) Treatment market. The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends, drivers
Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Research Rep …
The report entitled Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market : Size, Trends & Forecasts (2017-2021), provides analysis of the Global Castration-Resistant Prostate Cancer (CRPC) Treatment, with detailed analysis of market size and growth, and segmentation of the industry. The analysis includes the market by value, by segments, by application and by region. The report also provides the analysis of the Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market of
Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Res …
This report studies Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Astellas Johnson & Johnson Sanofi Dendreon Bayer To Get Sample Copy of Report visit @ http://www.qyresearchreports.com/sample/sample.php?rep_id=905816&type=E Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth